Pancreatic islet-specific overexpression of Reg3β protein induced the expression of pro-islet genes and protected the mice against streptozotocin-induced diabetes mellitus.
Reg family proteins have been implicated in islet β-cell proliferation, survival, and regeneration. The expression of Reg3β (pancreatitis-associated protein) is highly induced in experimental diabetes and acute pancreatitis, but its precise role has not been established. Through knockout studies, this protein was shown to be mitogenic, antiapoptotic, and anti-inflammatory in the liver and pancreatic acinars. To test whether it can promote islet cell growth or survival against experimental damage, we developed β-cell-specific overexpression using rat insulin I promoter, evaluated the changes in normal islet function, gene expression profile, and the response to streptozotocin-induced diabetes. Significant and specific overexpression of Reg3β was achieved in the pancreatic islets of RIP-I/Reg3β mice, which exhibited normal islet histology, β-cell mass, and in vivo and in vitro insulin secretion in response to high glucose yet were slightly hyperglycemic and low in islet GLUT2 level. Upon streptozotocin treatment, in contrast to wild-type littermates that became hyperglycemic in 3 days and lost 15% of their weight, RIP-I/Reg3β mice were significantly protected from hyperglycemia and weight loss. To identify specific targets affected by Reg3β overexpression, a whole genome DNA microarray on islet RNA isolated from the transgenic mice revealed more than 45 genes significantly either up- or downregulated. Among them, islet-protective osteopontin/SPP1 and acute responsive nuclear protein p8/NUPR1 were significantly induced, a result further confirmed by real-time PCR, Western blots, and immunohistochemistry. Our results suggest that Reg3β is unlikely an islet growth factor but a putative protector that prevents streptozotocin-induced damage by inducing the expression of specific genes.
Fraser Laboratories for Diabetes Research, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Xiaoquan
X
Xiong
Xiao
X
Wang
Bing
B
Li
Subrata
S
Chowdhury
Yarong
Y
Lu
Coimbatore B
CB
Srikant
Guang
G
Ning
Jun-Li
JL
Liu
D000818:Animals; D019610:Cytoprotection / Q000235:genetics; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced* / Q000235:genetics* / Q000473:pathology / Q000517:prevention & control; D005786:Gene Expression Regulation / Q000235:genetics; D018014:Gene Transfer Techniques; D005796:Genes / Q000502:physiology; D007328:Insulin / Q000235:genetics; D007515:Islets of Langerhans / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009928:Organ Specificity / Q000235:genetics; D000073718:Pancreatitis-Associated Proteins; D011401:Promoter Regions, Genetic / Q000502:physiology; D011506:Proteins / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D051381:Rats; D013311:Streptozocin; D015854:Up-Regulation / Q000235:genetics
D007328:Insulin; D000073718:Pancreatitis-Associated Proteins; D011506:Proteins; C000612141:REG3A protein, human; C490253:Reg3b protein, mouse; D013311:Streptozocin